- Aug 2022
-
www.theguardian.com www.theguardian.com
-
Beaumont, P. (2021, December 17). T-cells in Pfizer Covid jab recipients stay robust against severe illness. The Guardian. https://www.theguardian.com/world/2021/dec/17/t-cells-pfizer-covid-jab-robust-against-severe-illness-south-africa-research
-
-
www.medrxiv.org www.medrxiv.org
-
Sadoff, J., Gars, M. L., Cardenas, V., Shukarev, G., Vaissiere, N., Heerwegh, D., Truyers, C., Groot, A. M. de, Scheper, G., Hendriks, J., Ruiz-Guinazu, J., Struyf, F., Hoof, J. V., Douoguih, M., & Schuitemaker, H. (2021). Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting (p. 2021.08.25.21262569). https://doi.org/10.1101/2021.08.25.21262569
-
-
www.nytimes.com www.nytimes.com
-
Zimmer, C. (2021, June 6). We’ll Probably Need Booster Shots for Covid-19. But When? And Which Ones? The New York Times. https://www.nytimes.com/2021/06/06/science/covid-vaccine-boosters.html
-
-
www.theguardian.com www.theguardian.com
-
Davis, N. (2021, October 18). Valneva Covid vaccine could be as effective as Oxford jab, study suggests. The Guardian. https://www.theguardian.com/society/2021/oct/18/valneva-covid-vaccine-could-be-as-effective-as-oxford-jab-study-suggests
-
-
inst-fs-iad-prod.inscloudgate.net inst-fs-iad-prod.inscloudgate.net
-
Krause, P. R., Fleming, T. R., Peto, R., Longini, I. M., Figueroa, J. P., Sterne, J. A. C., Cravioto, A., Rees, H., Higgins, J. P. T., Boutron, I., Pan, H., Gruber, M. F., Arora, N., Kazi, F., Gaspar, R., Swaminathan, S., Ryan, M. J., & Henao-Restrepo, A.-M. (2021). Considerations in boosting COVID-19 vaccine immune responses. The Lancet, 4. https://doi.org/10.1016/S0140-6736(21)02046-8
Tags
- COVID-19
- vaccine efficacy
- science
- lang:en
- is:article
- immune response
- booster
- immunity
- Delta variant
- vaccine
- politics
Annotators
URL
-
-
www.medrxiv.org www.medrxiv.org
-
Collier, A. Y., Brown, C. M., Mcmahan, K., Yu, J., Liu, J., Jacob-Dolan, C., Chandrashekar, A., Tierney, D., Ansel, J. L., Rowe, M., Sellers, D., Ahmad, K., Aguayo, R., Anioke, T., Gardner, S., Siamatu, M., Rivera, L. B., Hacker, M. R., Madoff, L. C., & Barouch, D. H. (2021). Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts (p. 2021.10.18.21265113). https://doi.org/10.1101/2021.10.18.21265113
-
- Apr 2022
-
www.science.org www.science.org
-
Mathew, D., Giles, J. R., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., Kuri-Cervantes, L., Pampena, M. B., D’Andrea, K., Manne, S., Chen, Z., Huang, Y. J., Reilly, J. P., Weisman, A. R., Ittner, C. A. G., Kuthuru, O., Dougherty, J., Nzingha, K., … Wherry, E. J. (2020). Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science, 369(6508), eabc8511. https://doi.org/10.1126/science.abc8511
-
- Mar 2022
-
theconversation.com theconversation.com
-
Lee, A., Cheng, K. K., Cruickshank, S., & Greenhalgh, T. (n.d.). “We suppressed our scientific imagination”: Four experts examine the big successes and failures of the COVID response so far. The Conversation. Retrieved March 31, 2022, from http://theconversation.com/we-suppressed-our-scientific-imagination-four-experts-examine-the-big-successes-and-failures-of-the-covid-response-so-far-178705
-
-
www.news18.com www.news18.com
-
Corbevax: All About India’s First Protein Sub-Unit Covid Vaccine to be Given to 12-14 Age Group From Today. (2022, March 16). News18. https://www.news18.com/news/india/corbevax-all-about-indias-first-protein-sub-unit-covid-vaccine-to-be-given-to-12-14-age-group-from-today-4874345.html
-
-
twitter.com twitter.com
-
Anthony J Leonardi, PhD, MS. (2022, February 28). Damn, nice find https://t.co/cJRhB2k4zH [Tweet]. @fitterhappierAJ. https://twitter.com/fitterhappierAJ/status/1498113886846914567
-
- Feb 2022
-
www.theatlantic.com www.theatlantic.com
-
Yong, E. (2022, February 16). The Millions of People Stuck in Pandemic Limbo. The Atlantic. https://www.theatlantic.com/health/archive/2022/02/covid-pandemic-immunocompromised-risk-vaccines/622094/
-
-
www.nature.com www.nature.com
-
Adam, D. (2022). Will Omicron end the pandemic? Here’s what experts say. Nature, 602(7895), 20–21. https://doi.org/10.1038/d41586-022-00210-7
-
- Jan 2022
-
www.medrxiv.org www.medrxiv.org
-
Gentles, L. E., Kehoe, L., Crawford, K. H. D., Lacombe, K., Dickerson, J., Wolf, C., Yuan, J., Schuler, S., Watson, J. T., Nyanseor, S., Briggs-Hagen, M., Saydah, S., Midgley, C. M., Pringle, K., Chu, H., Bloom, J. D., & Englund, J. A. (2022). Dynamics of infection-elicited SARS-CoV-2 antibodies in children over time (p. 2022.01.14.22269235). medRxiv. https://doi.org/10.1101/2022.01.14.22269235
-
-
www.bmj.com www.bmj.com
-
Taylor, L. (2022). Covid-19: CoronaVac immunity is strongest after boosting with a different vaccine. BMJ, 376, o210. https://doi.org/10.1136/bmj.o210
-
-
healthpolicy-watch.news healthpolicy-watch.news
-
Backed By Science: Here’s How We Can Eliminate COVID-19 - Health Policy Watch. (2022, January 23). https://healthpolicy-watch.news/93258-2/
Tags
- strategy
- COVID-19
- prevention
- global coordination
- lang:en
- herd immunity
- immunity
- elimination
- pandemic management
- vaccine
- risk
- attitudes
- hospital
- variant
- airborne transmission
- global solidarity
- protection
- equity
- science
- Omicron
- vaccine plus
- mortality
- natural infection
- reinfection
- WHO
- temporary immune response
- is:webpage
Annotators
URL
-
-
www.theguardian.com www.theguardian.com
-
Davis, N., & correspondent, N. D. S. (2022, January 21). Covid reinfection: How likely are you to catch virus multiple times? The Guardian. https://www.theguardian.com/world/2022/jan/21/covid-reinfection-how-likely-are-you-to-catch-virus-multiple-times
-
-
-
Dolgin, E. (2022). Omicron thwarts some of the world’s most-used COVID vaccines. Nature. https://doi.org/10.1038/d41586-022-00079-6
-
-
www.medrxiv.org www.medrxiv.org
-
Home
Zuo, F., Abolhassani, H., Du, L., Piralla, A., Bertoglio, F., Campos-Mata, L. de, Wan, H., Schubert, M., Wang, Y., Sun, R., Cassaniti, I., Vlachiotis, S., Kumagai-Braesch, M., Andréll, J., Zhang, Z., Xue, Y., Wenzel, E. V., Calzolai, L., Varani, L., … Pan-Hammarström, Q. (2022). Heterologous immunization with inactivated vaccine followed by mRNA booster elicits strong humoral and cellular immune responses against the SARS-CoV-2 Omicron variant (p. 2022.01.04.22268755). https://doi.org/10.1101/2022.01.04.22268755
-
-
-
Iacobucci, G. (2022). Covid-19: Fourth vaccine doses—who needs them and why? BMJ, 376, o30. https://doi.org/10.1136/bmj.o30
-
-
www.newscientist.com www.newscientist.com
-
author.fullName}. (n.d.). 2022 preview: What will the coronavirus do next? New Scientist. Retrieved January 4, 2022, from https://www.newscientist.com/article/mg25233661-800-2022-preview-what-will-the-coronavirus-do-next/
-
-
www.theguardian.com www.theguardian.com
-
Davis, N., & correspondent, N. D. S. (2021, December 31). What do we know about the Omicron Covid variant so far? The Guardian. https://www.theguardian.com/world/2021/dec/31/what-do-we-know-about-the-omicron-covid-variant-so-far
-
- Dec 2021
-
twitter.com twitter.com
-
Eric Topol. (2021, October 19). Just published @ScienceTM With blunting of the immune response, why it is so important for pregnant women to get a Covid vaccine https://science.org/doi/10.1126/scitranslmed.abm2070 w/ @ScienceVisuals https://t.co/aCY6LP4Taa [Tweet]. @EricTopol. https://twitter.com/EricTopol/status/1450475410328850435
-
-
www.nature.com www.nature.com
-
Sefik, E., Israelow, B., Mirza, H., Zhao, J., Qu, R., Kaffe, E., Song, E., Halene, S., Meffre, E., Kluger, Y., Nussenzweig, M., Wilen, C. B., Iwasaki, A., & Flavell, R. A. (2021). A humanized mouse model of chronic COVID-19. Nature Biotechnology, 1–15. https://doi.org/10.1038/s41587-021-01155-4
-
-
www.nature.com www.nature.com
-
Adamo, S., Michler, J., Zurbuchen, Y., Cervia, C., Taeschler, P., Raeber, M. E., Sain, S. B., Nilsson, J., Moor, A. E., & Boyman, O. (2021). Signature of long-lived memory CD8+ T cells in acute SARS-CoV-2 infection. Nature, 1–9. https://doi.org/10.1038/s41586-021-04280-x
-
-
www.bmj.com www.bmj.com
-
Mahase, E. (2021). Covid-19: Antibody boost after third dose varies greatly by vaccine, study finds. BMJ, 375, n3011. https://doi.org/10.1136/bmj.n3011
-
-
www.statnews.com www.statnews.com
-
Cause for optimism on Omicron: Our immune systems aren’t blank slates. (2021, December 1). STAT. https://www.statnews.com/2021/12/01/a-reason-for-optimism-on-omicron-our-immune-systems-are-not-blank-slates/
Tags
- COVID-19
- previous infection
- vaccine efficacy
- lang:en
- Omicron
- immune response
- immunity
- vaccine
- variant
- immunology
- is:news
- protection
- mutation
Annotators
URL
-
-
assets.publishing.service.gov.uk assets.publishing.service.gov.uk
-
COVID-19 vaccine surveillance report—Week 47. (n.d.). 46.
Tags
- approval
- COVID-19
- vaccine efficacy
- lang:en
- clinical trials
- research
- immune response
- vaccine
- UK
- data
- UKHSA
- is:report
- protection
- safety profile
- delta
Annotators
URL
-
-
www.thelancet.com www.thelancet.com
-
Thiruvengadam, R., Awasthi, A., Medigeshi, G., Bhattacharya, S., Mani, S., Sivasubbu, S., Shrivastava, T., Samal, S., Rathna Murugesan, D., Koundinya Desiraju, B., Kshetrapal, P., Pandey, R., Scaria, V., Kumar Malik, P., Taneja, J., Binayke, A., Vohra, T., Zaheer, A., Rathore, D., … Garg, P. K. (2021). Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: A test-negative, case-control study and a mechanistic study of post-vaccination immune responses. The Lancet Infectious Diseases, S1473309921006800. https://doi.org/10.1016/S1473-3099(21)00680-0
-
- Nov 2021
-
www.thelancet.com www.thelancet.com
-
Wheatley, A. K., & Juno, J. A. (2021). COVID-19 vaccines in the age of the delta variant. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00688-5
-
-
www.thelancet.com www.thelancet.com
-
Thiruvengadam, R., Awasthi, A., Medigeshi, G., Bhattacharya, S., Mani, S., Sivasubbu, S., Shrivastava, T., Samal, S., Murugesan, D. R., Desiraju, B. K., Kshetrapal, P., Pandey, R., Scaria, V., Malik, P. K., Taneja, J., Binayke, A., Vohra, T., Zaheer, A., Rathore, D., … Garg, P. K. (2021). Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: A test-negative, case-control study and a mechanistic study of post-vaccination immune responses. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00680-0
-
-
www.nature.com www.nature.com
-
Reardon, S. (2021). Cuba’s bet on home-grown COVID vaccines is paying off. Nature. https://doi.org/10.1038/d41586-021-03470-x
-
-
-
Scott, Jake, Aaron Richterman, and Muge Cevik. ‘Covid-19 Vaccination: Evidence of Waning Immunity Is Overstated’. BMJ 374 (23 September 2021): n2320. https://doi.org/10.1136/bmj.n2320.
-
- Oct 2021
-
www.nature.com www.nature.com
-
Sun, W., Liu, Y., Amanat, F., González-Domínguez, I., McCroskery, S., Slamanig, S., Coughlan, L., Rosado, V., Lemus, N., Jangra, S., Rathnasinghe, R., Schotsaert, M., Martinez, J. L., Sano, K., Mena, I., Innis, B. L., Wirachwong, P., Thai, D. H., Oliveira, R. D. N., … Palese, P. (2021). A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses. Nature Communications, 12(1), 6197. https://doi.org/10.1038/s41467-021-26499-y
-
-
journalistsresource.org journalistsresource.org
-
Covering COVID-19 vaccine boosters: 4 tips and a timeline. (n.d.). Retrieved October 25, 2021, from https://journalistsresource.org/home/covid-19-boosters-tip-sheet/
-
-
www.immunology.org www.immunology.org
-
COVID-19 immunity: Natural infection compared to vaccination | British Society for Immunology. (n.d.). Retrieved October 10, 2021, from https://www.immunology.org/coronavirus/connect-coronavirus-public-engagement-resources/covid-immunity-natural-infection-vaccine
Tags
- COVID-19
- lang:en
- immune response
- immunity
- protection
- vaccine
- natural infection
- UK
- immunology
- infographic
- variant
- is:webpage
Annotators
URL
-
-
twitter.com twitter.com
-
Deepta Bhattacharya on Twitter. (n.d.). Twitter. Retrieved 4 October 2021, from https://twitter.com/deeptabhattacha/status/1441099377150332928
-
-
www.gavi.org www.gavi.org
-
Five reasons why it’s a terrible idea to hold a COVID-19 party (even if you’ve been vaccinated) | Gavi, the Vaccine Alliance. (n.d.). Retrieved October 3, 2021, from https://www.gavi.org/vaccineswork/five-reasons-why-its-terrible-idea-hold-covid-19-party-even-if-youve-been
-
-
www.theguardian.com www.theguardian.com
-
Flu and Covid jabs safe to be given at same time, study finds | Vaccines and immunisation | The Guardian. (n.d.). Retrieved October 1, 2021, from https://www.theguardian.com/society/2021/sep/30/flu-covid-jabs-safe-same-time-study?CMP=Share_iOSApp_Other
-
- Sep 2021
-
www.nature.com www.nature.com
-
Lee, J. W., Su, Y., Baloni, P., Chen, D., Pavlovitch-Bedzyk, A. J., Yuan, D., Duvvuri, V. R., Ng, R. H., Choi, J., Xie, J., Zhang, R., Murray, K., Kornilov, S., Smith, B., Magis, A. T., Hoon, D. S. B., Hadlock, J. J., Goldman, J. D., Price, N. D., … Heath, J. R. (2021). Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19. Nature Biotechnology, 1–11. https://doi.org/10.1038/s41587-021-01020-4
-
-
www.sandiegouniontribune.com www.sandiegouniontribune.com
-
Twitter, & Email. (2021, August 20). Vax facts: San Diego researchers debunk 7 common COVID-19 vaccine myths. San Diego Union-Tribune. https://www.sandiegouniontribune.com/news/health/story/2021-08-20/vax-facts-7-common-coronavirus-vaccine-myths-debunked
-
-
www.science.org www.science.org
-
Israelow, B., Mao, T., Klein, J., Song, E., Menasche, B., Omer, S. B., & Iwasaki, A. (2021). Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2. Science Immunology. https://doi.org/10.1126/sciimmunol.abl4509
-
- Aug 2021
-
www.biorxiv.org www.biorxiv.org
-
Liu, Y., Arase, N., Kishikawa, J., Hirose, M., Li, S., Tada, A., Matsuoka, S., Arakawa, A., Akamatsu, K., Ono, C., Jin, H., Kishida, K., Nakai, W., Kohyama, M., Nakagawa, A., Yamagishi, Y., Nakagami, H., Kumanogoh, A., Matsuura, Y., … Arase, H. (2021). The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines (p. 2021.08.22.457114). https://doi.org/10.1101/2021.08.22.457114
-
-
www.thebulwark.com www.thebulwark.com
-
What Is “Natural Immunity”? And Why Should You Get the Vaccine Even if You Already Had COVID? - The Bulwark. (n.d.). Retrieved August 11, 2021, from https://www.thebulwark.com/what-is-natural-immunity-and-why-should-you-get-the-vaccine-even-if-you-already-had-covid/
-
- Jul 2021
-
twitter.com twitter.com
-
Thushan de Silva on Twitter. (n.d.). Twitter. Retrieved 29 July 2021, from https://twitter.com/Thushan_deSilva/status/1418511974435115011
-
-
www.nejm.org www.nejm.org
-
Barouch, Dan H., Kathryn E. Stephenson, Jerald Sadoff, Jingyou Yu, Aiquan Chang, Makda Gebre, Katherine McMahan, et al. “Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.” New England Journal of Medicine 0, no. 0 (July 14, 2021): null. https://doi.org/10.1056/NEJMc2108829.
-
-
www.bmj.com www.bmj.com
-
Griffin, S. (2021). Covid-19: China’s CoronaVac vaccine offers 83.5% protection against symptomatic infection, interim analysis finds. BMJ, 374, n1755. https://doi.org/10.1136/bmj.n1755
-
-
www.nature.com www.nature.com
-
Collier, D. A., Ferreira, I. A. T. M., Kotagiri, P., Datir, R., Lim, E., Touizer, E., Meng, B., Abdullahi, A., Elmer, A., Kingston, N., Graves, B., Gresley, E. L., Caputo, D., Bergamaschi, L., Smith, K. G. C., Bradley, J. R., Ceron-Gutierrez, L., Cortes-Acevedo, P., Barcenas-Morales, G., … Gupta, R. K. (2021). Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature, 1–9. https://doi.org/10.1038/s41586-021-03739-1
-
- Jun 2021
-
www.nature.com www.nature.com
-
Pishko, A. M., Bussel, J. B., & Cines, D. B. (2021). COVID-19 vaccination and immune thrombocytopenia. Nature Medicine, 1–2. https://doi.org/10.1038/s41591-021-01419-1
-
-
-
Callaway, E. (2021). Mix-and-match COVID vaccines trigger potent immune response. Nature, 593(7860), 491–491. https://doi.org/10.1038/d41586-021-01359-3
-
- May 2021
-
-
Mallapaty, S. (2021). Scientists zero in on long-sought marker of COVID-vaccine efficacy. Nature, d41586-021-01372–01376. https://doi.org/10.1038/d41586-021-01372-6
-
-
www.10news.com www.10news.com
-
In-Depth: Delaying the second COVID-19 vaccine dose has benefits and drawbacks. (2021, May 20). KGTV. https://www.10news.com/news/in-depth/in-depth-delaying-the-second-covid-19-vaccine-dose-has-benefits-and-drawbacks
-
- Mar 2021
-
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov
-
Gray, Kathryn J., Evan A. Bordt, Caroline Atyeo, Elizabeth Deriso, Babatunde Akinwunmi, Nicola Young, Aranxta Medina Baez, et al. ‘COVID-19 Vaccine Response in Pregnant and Lactating Women: A Cohort Study’. MedRxiv: The Preprint Server for Health Sciences, 8 March 2021. https://doi.org/10.1101/2021.03.07.21253094.
-
-
www.health.com www.health.com
-
A Few People Developed a Rare Blood Disorder, Immune Thrombocytopenia, After Getting a COVID Vaccine | Health.com. (n.d.). Retrieved March 17, 2021, from https://www.health.com/condition/infectious-diseases/coronavirus/rare-blood-disorder-covid-vaccine-thrombocytopenia
-
-
www.nytimes.com www.nytimes.com
-
Mandavilli, A. (2021, January 28). Some Covid Survivors Have Antibodies That Attack the Body, not Virus. The New York Times. https://www.nytimes.com/2020/10/27/health/covid-antibodies-autoimmunity.html
-
-
www-nature-com.ezp.lib.cam.ac.uk www-nature-com.ezp.lib.cam.ac.uk
-
Nature Editorial. (2020, October 23). The race to make COVID antibody therapies cheaper and more potent. Nature. https://www.nature.com/articles/d41586-020-02965-3?utm_source=twt_nnc&utm_medium=social&utm_campaign=naturenews&sf239165668=1&error=cookies_not_supported&code=2b2dd7c6-d01f-4057-8389-3be656a7ba58
-
-
psyarxiv.com psyarxiv.com
-
Karlsson, L. C., Soveri, A., Lewandowsky, S., Karlsson, L., Karlsson, H., Nolvi, S., … Antfolk, J. (2021, March 4). The Behavioral Immune System and Vaccination Intentions During the Coronavirus Pandemic. https://doi.org/10.31234/osf.io/r8uaz
Tags
- is:preprint
- COVID-19
- intention
- lang:en
- germ aversion
- individual differences
- immune response
- vaccine hesitancy
- behavioural immune system
- vaccination
- behavioral science
- vulnerable
- evolution
- health psychology
- disgust
- perceived infectability
- evolutionary psychology
- contaminant aversion
- social science
Annotators
URL
-
- Feb 2021
-
twitter.com twitter.com
-
Andrew💙Croxford. (2020, December 3). NEW THREAD: possible development of anti-Syncytin responses after immunization with the SARS-CoV-2 spike protein-coding mRNA vaccines, based on a ‘homologous’ region shared between these proteins. [Tweet]. @andrew_croxford. https://twitter.com/andrew_croxford/status/1334593606196187136
-
-
twitter.com twitter.com
-
Susan Cole-Haley on Twitter. (n.d.). Twitter. Retrieved 17 February 2021, from https://twitter.com/susancolehaley/status/1340231804431773699
-
-
-
Report of 8% vaccine efficacy for elderly debunked by German government. (14:24:16+00:00). Full Fact. https://fullfact.org/health/german-astrazeneca-8-percent-handelsblatt/
-
- Dec 2020
-
mailchi.mp mailchi.mp
-
🔥 Your COVID Roundup, Week #31. (n.d.). Retrieved December 9, 2020, from https://mailchi.mp/8338eb3924db/your-covid-roundup-7106445?e=feb8bf1ac8
-
- Oct 2020
-
www.npr.org www.npr.org
-
Aubrey, A. (2020). Will Kids Get A COVID-19 Vaccine? Pfizer To Expand Trial To Ages 12 And Up. NPR. https://www.npr.org/sections/health-shots/2020/10/13/923248377/will-kids-get-a-covid-19-vaccine-pfizer-to-expand-trial-to-ages-12-and-up?t=1602805163253
-
-
-
Sia, S. F., Yan, L.-M., Chin, A. W. H., Fung, K., Choy, K.-T., Wong, A. Y. L., Kaewpreedee, P., Perera, R. A. P. M., Poon, L. L. M., Nicholls, J. M., Peiris, M., & Yen, H.-L. (2020). Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature, 583(7818), 834–838. https://doi.org/10.1038/s41586-020-2342-5
-
-
www.pnas.org www.pnas.org
-
Bosco-Lauth, A. M., Hartwig, A. E., Porter, S. M., Gordy, P. W., Nehring, M., Byas, A. D., VandeWoude, S., Ragan, I. K., Maison, R. M., & Bowen, R. A. (2020). Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2013102117
-
-
www.theguardian.com www.theguardian.com
-
Scientists study whether immune response wards off or worsens Covid. (2020, October 4). The Guardian. http://www.theguardian.com/science/2020/oct/04/scientists-study-whether-immune-response-wards-off-or-worsens-covid
-
- Sep 2020
-
www.thelancet.com www.thelancet.com
-
Felsenstein, S., & Hedrich, C. M. (2020). COVID-19 in children and young people. The Lancet Rheumatology, 2(9), e514–e516. https://doi.org/10.1016/S2665-9913(20)30212-5
-
- Aug 2020
-
science.sciencemag.org science.sciencemag.org
-
Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., Mallal, S., Lammers, M., Rubiro, P., Quiambao, L., Sutherland, A., Yu, E. D., Antunes, R. da S., Greenbaum, J., Frazier, A., … Weiskopf, D. (2020). Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. https://doi.org/10.1126/science.abd3871
-
-
-
Felipe, L. S., Vercruysse, T., Sharma, S., Ma, J., Lemmens, V., Looveren, D. van, Javarappa, M. P. A., Boudewijns, R., Malengier-Devlies, B., Kaptein, S. F., Liesenborghs, L., Keyzer, C. D., Bervoets, L., Rasulova, M., Seldeslachts, L., Jansen, S., Yakass, M. B., Quaye, O., Li, L.-H., … Dallmeier, K. (2020). A single-dose live-attenuated YF17D-vectored SARS-CoV2 vaccine candidate. BioRxiv, 2020.07.08.193045. https://doi.org/10.1101/2020.07.08.193045
-
-
-
Xu, G., Qi, F., Li, H., Yang, Q., Wang, H., Wang, X., Liu, X., Zhao, J., Liao, X., Liu, Y., Amit, I., Liu, L., Zhang, S., & Zhang, Z. (2020). The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing. MedRxiv, 2020.08.15.20175638. https://doi.org/10.1101/2020.08.15.20175638
-
-
www.thelancet.com www.thelancet.com
-
Zhu, F.-C., Guan, X.-H., Li, Y.-H., Huang, J.-Y., Jiang, T., Hou, L.-H., Li, J.-X., Yang, B.-F., Wang, L., Wang, W.-J., Wu, S.-P., Wang, Z., Wu, X.-H., Xu, J.-J., Zhang, Z., Jia, S.-Y., Wang, B.-S., Hu, Y., Liu, J.-J., … Chen, W. (2020). Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: A randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(20)31605-6
-
-
www.biorxiv.org www.biorxiv.org
-
Qin, M., Cao, Z., Wen, J., Yu, Q., Liu, C., Wang, F., Yang, F., Li, Y., Fishbein, G., Yan, S., Xu, B., Hou, Y., Ning, Z., Nie, K., Jiang, N., Liu, Z., Wu, J., Yu, Y., Li, H., … Lu, Y. (2020). An Antioxidant Enzyme Therapeutic for COVID-19. BioRxiv, 2020.07.15.205211. https://doi.org/10.1101/2020.07.15.205211
-
-
www.jpeds.com www.jpeds.com
-
Yonker, L. M., Neilan, A. M., Bartsch, Y., Patel, A. B., Regan, J., Arya, P., Gootkind, E., Park, G., Hardcastle, M., John, A. S., Appleman, L., Chiu, M. L., Fialkowski, A., Flor, D. D. la, Lima, R., Bordt, E. A., Yockey, L. J., D’Avino, P., Fischinger, S., … Fasano, A. (2020). Pediatric SARS-CoV-2: Clinical Presentation, Infectivity, and Immune Responses. The Journal of Pediatrics, 0(0). https://doi.org/10.1016/j.jpeds.2020.08.037
-
-
-
Bangaru, S., Ozorowski, G., Turner, H. L., Antanasijevic, A., Huang, D., Wang, X., Torres, J. L., Diedrich, J. K., Tian, J.-H., Portnoff, A. D., Patel, N., Massare, M. J., Yates, J. R., Nemazee, D., Paulson, J. C., Glenn, G., Smith, G., & Ward, A. B. (2020). Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate. BioRxiv, 2020.08.06.234674. https://doi.org/10.1101/2020.08.06.234674
-
-
www.nature.com www.nature.com
-
Ledford, H. (2020). What the immune response to COVID-19 says about the prospects for a vaccine. Nature. https://doi.org/10.1038/d41586-020-02400-7
-
-
www.cnn.com www.cnn.com
-
CNN, J. G., Naomi Thomas, Dana Vigue and Jacqueline Howard. (n.d.). Oxford’s Covid-19 vaccine appears safe and induces immune response, early results suggest. CNN. Retrieved August 2, 2020, from https://www.cnn.com/2020/07/20/health/oxford-covid-19-vaccine-results-cansino-pfizer-study/index.html
-
- Jul 2020
-
www.thelancet.com www.thelancet.com
-
Peeling, Rosanna W., Catherine J. Wedderburn, Patricia J. Garcia, Debrah Boeras, Noah Fongwen, John Nkengasong, Amadou Sall, Amilcar Tanuri, and David L. Heymann. ‘Serology Testing in the COVID-19 Pandemic Response’. The Lancet Infectious Diseases 0, no. 0 (17 July 2020). https://doi.org/10.1016/S1473-3099(20)30517-X.
Tags
- commercially available
- COVID-19
- lang:en
- viral infectivity
- immune response
- rapid immunodiagnostic tests
- situational analysis
- community
- surveillance
- host response
- control programmes
- global cooperation
- serology
- symptomatic patients
- public health
- is:report
- serology testing
- rapid serology tests
- international solidarity
- molecular diagnostics
Annotators
URL
-
-
psyarxiv.com psyarxiv.com
-
Adam-Troian, J., & Bagci, S. (2020). The pathogen paradox: Evidence that perceived COVID-19 threat is associated with both pro- and anti-immigrant attitudes. https://doi.org/10.31234/osf.io/948ch
-
- Jun 2020
-
www.nature.com www.nature.com
-
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., Su, K., Zhang, F., Gong, J., Wu, B., Liu, X.-M., Li, J.-J., Qiu, J.-F., Chen, J., & Huang, A.-L. (2020). Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nature Medicine, 1–5. https://doi.org/10.1038/s41591-020-0965-6
-
-
www.theatlantic.com www.theatlantic.com
-
Yong, E. (2020, June 4). COVID-19 Can Last for Several Months. The Atlantic. https://www.theatlantic.com/health/archive/2020/06/covid-19-coronavirus-longterm-symptoms-months/612679/
-
-
www.biorxiv.org www.biorxiv.org
-
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., Hagglof, T., Oliveira, T. Y., Viant, C., Hurley, A., Hoffmann, H.-H., Millard, K. G., Kost, R. G., Cipolla, M., Gordon, K., … Nussenzweig, M. C. (2020). Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals [Preprint]. Immunology. https://doi.org/10.1101/2020.05.13.092619
-
-
twitter.com twitter.com
-
Crotty, S. (2020, May 14). "Our new paper rapidly studied T cell + antibody immune responses in average COVID-19 cases. This is good news in multiple ways, including coronavirus vaccines. @ljiresearch cell.com/cell/fulltext/..." Twitter. https://twitter.com/profshanecrotty/status/1261052353773363200
-